ESCC
Oncology·MeSH: Colonic Neoplasms
5 drugs in development·5 companies·1 clinical trial
Drug Pipeline by Phase
Approved(1)
| Drug | Company |
|---|---|
| tevimbra | BeOne Medicines Ltd. (ONC) |
Phase 3(2)
Phase 2(1)
| Drug | Company |
|---|---|
| Serplulimab | ENANTA PHARMACEUTICALS INC (ENTA) |
Phase 1(1)
| Drug | Company |
|---|---|
| tagmokitug | Coherus Oncology, Inc. (CHRS) |
Compare drugs
Frequently asked questions
How many drugs are in development for ESCC?
BioSniper tracks 5 drugs in development for ESCC across 5 companies.
How many clinical trials target ESCC?
There are 1 clinical trial targeting ESCC tracked by BioSniper.
Deep-dive into ESCC
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis